Press "Enter" to skip to content

New patent for Helsinn Hlthcare drug AKYNZEO

0
Copyright © DrugPatentWatch. Originally published at New patent for Helsinn Hlthcare drug AKYNZEO

Annual Drug Patent Expirations for AKYNZEO
Annual Drug Patent Expirations for AKYNZEO

Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are fifteen patents protecting this drug.

This drug has two hundred and twenty patent family members in sixty-eight countries.

The generic ingredient in AKYNZEO is fosnetupitant chloride hydrochloride; palonosetron hydrochloride. One supplier is listed for this compound. Additional details are available on the fosnetupitant chloride hydrochloride; palonosetron hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Helsinn Hlthcare drug AKYNZEO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!